Treatment selection after imatinib resistance in chronic myeloid leukemia.

Treatment selection after imatinib resistance in chronic myeloid leukemia.

Item
http://www.wikidata.org/entity/Q37431597
AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistancePonatinib in refractory Philadelphia chromosome-positive leukemias.Decreased level of recent thymic emigrants in CD4+ and CD8+T cells from CML patientsAberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia.Novel dual Src/Abl inhibitors for hematologic and solid malignancies.Proliferation inhibition and apoptosis induction of imatinib-resistant chronic myeloid leukemia cells via PPP2R5C down-regulation.Long-term outcomes in the second-line treatment of chronic myeloid leukemia: a review of tyrosine kinase inhibitorsOutcome of treatment of chronic myeloid leukemia with second-generation tyrosine kinase inhibitors after imatinib failureUpregulated TCRζ enhances interleukin-2 production in T-cells from patients with CML.Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors.Nilotinib-Induced Keratosis Pilaris.Pleural/pericardic effusions during dasatinib treatment: incidence, management and risk factors associated to their development.Investigating critical genes and gene interaction networks that mediate cyclophosphamide sensitivity in chronic myelogenous leukemiaHealthcare utilization and costs associated with tyrosine kinase inhibitor switching in patients with chronic myeloid leukemia.Evaluation of healthcare resource utilization and incremental economic burden of patients with chronic myeloid leukemia after disease progression to blast phase.
P2860

Treatment selection after imatinib resistance in chronic myeloid leukemia.

Item
http://www.wikidata.org/entity/Q37431597
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment selection after imatinib resistance in chronic myeloid leukemia.
@en
Treatment selection after imatinib resistance in chronic myeloid leukemia.
@nl
type
label
Treatment selection after imatinib resistance in chronic myeloid leukemia.
@en
Treatment selection after imatinib resistance in chronic myeloid leukemia.
@nl
prefLabel
Treatment selection after imatinib resistance in chronic myeloid leukemia.
@en
Treatment selection after imatinib resistance in chronic myeloid leukemia.
@nl
P1433
P1476
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Treatment selection after imatinib resistance in chronic myeloid leukemia.
@en
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P921